Clinical Scoring and Validation of a Comprehensive AI-powered Tumour Content and Lung Macrodissection Algorithm
Learn more about Lung Macrodissect AI, an AI-based tool for tumor content quantification and ROI selection guidance.
Learn more about Lung Macrodissect AI, an AI-based tool for tumor content quantification and ROI selection guidance.
Read this white paper to learn about the importance of integration and interoperability in digital pathology and explore examples of how flexible solutions like HALO AP® can enhance workflow efficiency and diagnostic accuracy.
HALO AP Integrations Read More »
Download our brochure to learn more about how HALO AP®, the CE-IVDR-cleared image management system and HALO AP Dx, FDA 510(k)-cleared for primary diagnosis, are deployed to improve clinical workflows
HALO AP® and HALO AP Dx Brochure Read More »
Learn how this AI-powered tool standardized breast cancer biomarker quantification to include HER2 low and ultralow.
Breast IHC AI Brochure Read More »
Discover how our Cloud Services team can provide a secure, scalable, and flexible cloud deployment of HALO AP.
HALO AP® Cloud Services Brochure Read More »
Learn how the optimized, scalable infrastructure provided by Indica Labs Cloud Services enables the rapid development and robust collaboration of our AI Diagnostics group, powering the next generation of automated AI-based decision support tools.
Cloud Services and AI Diagnostics Case Study Read More »
Learn more about Nottingham University Hospitals NHS Trust’s transition to digital pathology and how HALO AP® has played a pivotal role in improving diagnostic efficiency and patient care.
HALO AP® NUH Case Study Read More »
Discover how the seamless integration of third-party image analysis algorithms, such as DeepDx from Deep Bio, with HALO AP® can benefit your lab.
HALO AP® Deep Bio Case Study Read More »
Read about the development and validation of an AI-based PD-L1 scoring algorithm for HALO AP®.
Learn more about the development and validation of an AI-based molecular pathology algorithm for estimating tumour cells in lung adenocarcinoma.